Atlas Trials

Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke

Clinical trial NCT07763405 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07763405
Sponsor
Xinqiao Hospital of Chongqing
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ischemic Stroke, Acute
Start date
2026-11-01
Primary completion
2028-12-31
Enrollment
1196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.